Who is sponsoring NCT04318847?

NCT04318847 is sponsored by Lizar Aguirre Pascasio.

What drugs are being tested in NCT04318847?

Interventions in NCT04318847: Ondansetron 4 MG.

What condition does NCT04318847 study?

NCT04318847 studies Vomiting in Infants and/or Children.

Is NCT04318847 still recruiting?

NCT04318847 is currently status unknown. Last updated 21 April 2021.

Last reviewed 2021-04-21 · How we verify

NCT04318847

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy and Safety of the Administration of Ondansetron Versus Habitual Clinical Practice for the Treatment of Vomiting in Children With Mild and Moderate Dehydration: Randomized Clinical Trial

Status unknown Phase 4 Last updated 21 April 2021

What this trial tests

Phase 4 trial testing Ondansetron 4 MG in Vomiting in Infants and/or Children in 220 participants. Status unknown.

Timeline

10 October 2021

Primary endpoint
10 April 2023

10 April 2023

Quick facts

Lead sponsor	Lizar Aguirre Pascasio
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	220
Start date	10 October 2021
Primary completion	10 April 2023
Estimated completion	10 April 2023

Drugs / interventions tested

Ondansetron 4 MG — full drug profile →

Conditions studied

Vomiting in Infants and/or Children — all drugs for Vomiting in Infants and/or Children →

Sponsor

Lizar Aguirre Pascasio

Who can join

Adults 4 to 13, any sex, with Vomiting in Infants and/or Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial is intended to evaluate the efficacy and safety of the administration of ondansetron in children with mild-moderate dehydration. The target population will be children between 4 and 13 years old who present vomiting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ondansetron 4 MG

Trials testing the same drug.

NCT04606264 — Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data · Phase 3 · completed
NCT05221151 — Melatonin vs Pregabalin for Anxiolysis and Sedation · Phase 4 · completed
NCT05127876 — Ephedrine Versus Ondansetron During Cesarean Delivery · Phase 4 · completed
NCT04983498 — Enhanced Recovery Pathway for Endoscopy · Phase 4 · withdrawn
NCT04191694 — Chewing Gum to Prevent Nausea and Vomiting After Caesarean Section Under Spinal Anaesthesia · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04318847 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lizar Aguirre Pascasio
Last refreshed: 21 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04318847.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing